Increased expression of insulin-like growth factor-binding protein-3 is implicated in erectile dysfunction in two-kidney one-clip hypertensive rats after propranolol treatment

Asian Journal of Andrology

Volumn 13, Issue 6, 2011, Pages 851-855

  Zhou, Zhang Yan ^a   Yang, Zhong Hua ^a   Wang, Xing Huan ^a   Cao, Hong ^a   Chen, Dong ^a   Wang, Yong Zhi ^a   Zhou, Hai Hong ^a   Peng, Mou ^a   Liu, Quan Liang ^a   Wan, Shao Ping ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

erectile dysfunction; insulin like growth factor binding protein 3; propranolol; two kidney one clip hypertension

Indexed keywords

CYCLIC GMP; MESSENGER RNA; PROPRANOLOL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; HYPERTENSION; MALE; NERVE STIMULATION; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; HYPERTENSION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; PROPRANOLOL; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80755127153     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.99     Document Type: Article

References (19)

1. Lue TF. Erectile dysfunction. N Engl J Med 2000; 342: 1802-13. (Pubitemid 30390241)
2. Fogari R, Zoppi A, Corradi L, Mugellini A, Poletti L et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 1998; 11: 1244-7.
3. Shabsigh R, Perelman MA, Lockhart DC, Lue TF, Broderick GA. Health issues of men: prevalence and correlates of erectile dysfunction. J Urol 2005; 174: 662-7. (Pubitemid 40981626)
4. Cervenka L, Horacek V, Vaneckova I, Hubacek JA, Oliverio MI et al. Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension 2002; 40: 735-41. (Pubitemid 35278612)
5. Lazartigues E, Lawrence AJ, Lamb FS, Davisson RL. Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery. Circ Res 2004; 95: 523-31. (Pubitemid 39193248)
6. Hiyoshi H, Yayama K, Takano M, Okamoto H. Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension 2005; 45: 967-73. (Pubitemid 40628945)
7. Linder AE, Bendhack LM. Endothelin-1-induced contraction is impaired in the tail artery of renal hypertensive rats. Vascul Pharmacol 2002; 39: 77-82. (Pubitemid 36398248)
8. Soh J, Katsuyama M, Ushijima S, Mizutani Y, Kawauchi A et al. Localization of increased insulin-like growth factor binding protein-3 in diabetic rat penis: implications for erectile dysfunction. Urology 2007; 70: 1019-23. (Pubitemid 350192595)
9. Pacca SR, de Azevedo AP, de Oliveira CF, de Luca IM, de Nucci G et al. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. J Cardiovasc Pharmacol 2002; 39: 201-7. (Pubitemid 34093539)
10. Pu XY, Hu LQ, Wang HP, Luo YX, Wang XH. Improvement in erectile dysfunction after insulin-like growth factor-1 gene therapy in diabetic rats. Asian J Androl 2007; 9: 83-91.
11. Vorwerk P, Oh Y, Lee PD, Khare A, Rosenfeld RG. Synthesis of IGFBP-3 fragments in a baculovirus system and characterization of monoclonal anti-IGFBP-3 antibodies. J Clin Endocrinol Metab 1997; 82: 2368-70. (Pubitemid 27287614)
12. Kasper JS, Liu Y, Pollak MN, Rifai N, Giovannucci E. Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control 2008; 19: 703-10.
13. Bochinski D, Hsieh PS, Nunes L, Lin GT, Lin CS et al. Effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 complex in cavernous nerve cryoablation. Int J Impot Res 2004; 16: 418-23. (Pubitemid 39319041)
14. Jeschke MG, Finnerty CC, Kulp GA, Przkora R, Mlcak RP et al. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit Care Med 2008; 9: 209-16. (Pubitemid 351355027)
15. Bivalacqua TJ, Usta MF, Kendirci M, Pradhan L, Alvarez X et al. Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med 2005; 2: 187-97. (Pubitemid 40468173)
16. Lamina S, Okoye CG, Dagogo TT. Managing erectile dysfunction in hypertension: the effects of a continuous training programme on biomarker of inflammation. BJU Int 2009; 103: 1218-21.
17. Watts GF, Chew KK, Stuckey BG. The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention. Nat Clin Pract Cardiovasc Med 2007; 4: 263-73. (Pubitemid 46672115)
18. Gur S, Kadowitz PJ, Gurkan L, Chandra S, Dewitt SY et al. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil. BJU Int 2010; 106: 78-83.
19. Spessoto LC, Cordeiro JA, de Godoy JM. Effect of systemic arterial pressure on erectile dysfunction in the initial stages of chronic arterial insufficiency. BJU Int 2010; 106: 1723-5.